Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q6)Mar 31, 2025 | (FY)Sep 30, 2024 | (Q6)Mar 31, 2024 | (FY)Sep 30, 2023 | (Q6)Mar 31, 2023 | (FY)Sep 30, 2022 | (Q6)Mar 31, 2022 | (FY)Sep 30, 2021 | (Q6)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -20.17%827K | ---- | 21.60%1.04M | ---- | 2,942.86%852K | ---- | -80.95%28K | ---- | -75.29%147K | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -11.90%-47K | ---- | -4,100.00%-42K | ---- | ---1K | ---- | ---- | ---- | ---- | ---- |
| Interest expense - adjustment | -50.00%5K | ---- | 0.00%10K | ---- | -16.67%10K | ---- | -14.29%12K | ---- | -26.32%14K | ---- |
| Impairment and provisions: | ---- | ---- | ---- | ---- | --37K | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | --37K | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | -183.33%-34K | ---- | 0.00%-12K | ---- | ---12K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | -183.33%-34K | ---- | 0.00%-12K | ---- | ---12K | ---- |
| Depreciation and amortization: | 10.11%817K | ---- | 17.03%742K | ---- | 28.86%634K | ---- | 14.95%492K | ---- | 11.46%428K | ---- |
| -Amortization of intangible assets | 46.15%19K | ---- | -7.14%13K | ---- | -30.00%14K | ---- | 100.00%20K | ---- | -9.09%10K | ---- |
| -Other depreciation and amortization | -16.67%-42K | ---- | -71.43%-36K | ---- | -162.50%-21K | ---- | ---8K | ---- | ---- | ---- |
| Adjustment items | -16.67%-42K | ---- | -71.43%-36K | ---- | -162.50%-21K | ---- | ---8K | ---- | ---- | ---- |
| Operating profit before the change of operating capital | -8.77%1.56M | ---- | 15.78%1.71M | ---- | 188.48%1.48M | ---- | -11.27%512K | ---- | -40.02%577K | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 85.32%-16K | ---- | -475.86%-109K | ---- | 109.03%29K | ---- | -105.48%-321K | ---- | 197.20%5.86M | ---- |
| Accounts receivable (increase)decrease | -238.71%-258K | ---- | 182.30%186K | ---- | 63.61%-226K | ---- | -175.55%-621K | ---- | 173.46%822K | ---- |
| Accounts payable increase (decrease) | 110.85%28K | ---- | -393.18%-258K | ---- | 833.33%88K | ---- | 85.71%-12K | ---- | 90.04%-84K | ---- |
| prepayments (increase)decrease | -411.11%-28K | ---- | -81.63%9K | ---- | -77.10%49K | ---- | 202.39%214K | ---- | -4,280.00%-209K | ---- |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | 71.72%-1.54M | ---- | -177.96%-5.46M | ---- |
| Cash from business operations | -16.38%1.29M | ---- | 8.54%1.54M | ---- | 180.01%1.42M | ---- | -217.44%-1.77M | ---- | 6,656.52%1.51M | ---- |
| Other taxs | -3,400.00%-175K | ---- | -103.57%-5K | ---- | 1,176.92%140K | ---- | 92.12%-13K | ---- | -38.66%-165K | ---- |
| Special items of business | ---- | -68.08%218K | ---- | 56.65%683K | ---- | 136.95%436K | ---- | -555.56%-1.18M | ---- | 76.65%-180K |
| Net cash from operations | -27.53%1.11M | -68.08%218K | -1.54%1.53M | 56.65%683K | 187.28%1.56M | 136.95%436K | -232.84%-1.78M | -555.56%-1.18M | 1,045.77%1.34M | 76.65%-180K |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 11.90%47K | ---- | 4,100.00%42K | ---- | --1K | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | 240.00%119K | ---- | -58.33%35K | ---- | --84K | ---- |
| Purchase of fixed assets | ---- | ---- | 58.28%-300K | ---- | 30.60%-719K | ---- | 30.52%-1.04M | ---- | 47.35%-1.49M | ---- |
| Purchase of intangible assets | ---30K | ---- | ---- | ---- | ---- | ---- | ---67K | ---- | ---- | ---- |
| Other items in the investment business | -93.88%30K | -93.96%29K | --490K | 431.03%480K | ---- | -526.47%-145K | --56K | 104.96%34K | ---- | 65.23%-685K |
| Net cash from investment operations | -79.74%47K | -93.96%29K | 138.73%232K | 431.03%480K | 40.81%-599K | -526.47%-145K | 28.07%-1.01M | 104.96%34K | 49.68%-1.41M | 65.23%-685K |
| Net cash before financing | -34.39%1.16M | -78.76%247K | 84.24%1.77M | 299.66%1.16M | 134.26%958K | 125.39%291K | -4,268.75%-2.8M | -32.49%-1.15M | 97.82%-64K | 68.44%-865K |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---- | ---- | ---- | 91.51%-9K | ---- | -3.92%-106K | ---- | -2.00%-102K | ---- |
| Interest paid - financing | 50.00%-5K | ---- | 0.00%-10K | ---- | 16.67%-10K | ---- | 14.29%-12K | ---- | 26.32%-14K | ---- |
| Other items of the financing business | ---- | -5.88%-18K | ---- | 34.62%-17K | ---- | 98.39%-26K | ---- | -2,171.83%-1.61M | ---- | -12.70%-71K |
| Net cash from financing operations | 2.94%-33K | -5.88%-18K | 20.93%-34K | 34.62%-17K | 69.50%-43K | 98.39%-26K | -0.71%-141K | -2,171.83%-1.61M | 1.41%-140K | -12.70%-71K |
| Net Cash | -35.01%1.13M | -80.02%229K | 89.18%1.73M | 332.45%1.15M | 131.15%915K | 109.60%265K | -1,339.71%-2.94M | -194.76%-2.76M | 93.38%-204K | 66.62%-936K |
| Begining period cash | 100.52%3.45M | 100.52%3.45M | 113.38%1.72M | 113.38%1.72M | -78.45%807K | -78.45%807K | -5.17%3.74M | -5.17%3.74M | -43.82%3.95M | -43.82%3.95M |
| Cash at the end | 32.58%4.58M | 28.38%3.68M | 100.52%3.45M | 167.54%2.87M | 113.38%1.72M | 8.83%1.07M | -78.45%807K | -67.30%985K | -5.17%3.74M | -28.69%3.01M |
| Cash balance analysis | ||||||||||
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Foo Kon Tan LLP | -- | Foo Kon Tan LLP | -- | Foo Kon Tan LLP | -- | Foo Kon Tan LLP | -- | Foo Kon Tan LLP | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.